Broadcom named strategic vendor for Walmart virtualization solutions
Today, Haleon plc (LSE/NYSE:HLN) disclosed a shareholding transaction involving Tamara Rogers, the company’s Chief Marketing Officer. The announcement was made in accordance with the UK Market Abuse Regulation, as reported in a SEC 6-K filing.
Rogers, identified as a Person Discharging Managerial Responsibilities (PDMR), acquired ordinary shares of £0.01 each in Haleon. The transaction took place on Thursday on the London Stock Exchange (LON:LSEG) (XLON) as part of a dividend reinvestment plan. The shares were acquired at a price of £4.01403 per share, with a total volume of five shares.
Haleon, a global leader in the consumer health sector, is known for its portfolio of brands such as Advil, Centrum, and Sensodyne. This transaction is part of the company’s regular disclosure requirements for managerial personnel under UK regulations.
The notification was signed by Amanda Mellor, the Company Secretary, and is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.